Astra Zeneca is closing its Fort Washington office, and filed a notice with the state of Pennsylvania that the move will affect 134 people.
A spokeswoman said the jobs will be based out of Wilmington as of October 3 and "there have not been any reductions as part of the decision to close the Fort Washington office."
Astra Zeneca spokeswoman Abigail Bozarth said employees who meet certain criteria, and cannot commute to Wilmington, "are eligible for severance."
The jobs include marketing, medical affairs, sales and "other enabling functions" for AstraZeneca's U.S. diabetes business "and those roles will be relocating to the company's North America headquarters in Delaware.
"We are consolidating our footprint to create efficiencies and reduce expenses," the company said in a statement.
"Co-locating Fort Washington-based employees in Wilmington will also provide greater opportunity for closer collaboration and alignment within the U.S. business," the company said. "We recognize change is difficult and are fully committed to working with employees to ensure they have the flexibility they need through this transition."